Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage alzheimer’s disease John C. MorrisJoseph L. Price OriginalPaper Pages: 101 - 118
Biological markers and the treatment of Alzheimer’s Disease Douglas Galasko OriginalPaper Pages: 119 - 125
Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer’s disease Charles Glabe OriginalPaper Pages: 137 - 145
Role of apoE/Aβ interactions in the pathogenesis of Alzheimer’s disease and cerebral amyloid angiopathy David M. Holtzman OriginalPaper Pages: 147 - 155
Implication of APP secretases in notch signaling Dieter HartmannJos TournoyBart De Strooper OriginalPaper Pages: 171 - 181
γ-Secretase inhibitors as molecular probes of presenilin function Michael S. Wolfe OriginalPaper Pages: 199 - 204
Dysregulation of cellular calcium homeostasis in Alzheimer’s disease Mark P. MattsonSic L. Chan OriginalPaper Pages: 205 - 224
Lewy body pathology in Alzheimer’s disease Paul T. KotzbauerJohn Q. TrojanowskiVirginia M.-Y. Lee OriginalPaper Pages: 225 - 232
Genetically engineered models relevant to neurodegenerative disorders Philip C. WongHuaibin CaiDonald L. Price OriginalPaper Pages: 233 - 257
Potential treatment opportunities for Alzheimer’s disease through inhibition of secretases and Aβ immunization Dale SchenkDora GamesPeter Seubert OriginalPaper Pages: 259 - 267